Key result
Intravenous magnesium sulfate effectively treated torsades de pointes in children with long QT syndrome, with 5 of 6 patients responding completely to an initial bolus.
Why the study?
Does intravenous magnesium sulfate effectively treat Torsades de Pointes in children with Long QT Syndrome?
Observational (n=6)
Does intravenous magnesium sulfate effectively treat Torsades de Pointes in children with Long QT Syndrome?
Intravenous magnesium sulfate is an effective treatment for Torsades de Pointes in children with Long QT Syndrome, with an optimal bolus of 3-12 mg/kg.
Answers are grounded in this paper and cite their sources.
May support IV magnesium for pediatric LQTS torsades; leaves open need for prospective confirmation before practice change.
BACKGROUND: Intravenous administration of magnesium sulphate (MgSO(4)) is a very effective and safe treatment for torsades de pointes (TdP) associated with acquired long QT syndrome (LQTS) in adults. Discussed here is the efficacy of MgSO(4) for TdP in children with congenital and acquired LQTS. METHODS: The optimal MgSO(4) dosage and serum magnesium (SMg) was determined in six consecutive children with TdP; four had congenital LQTS and two had acquired LQTS. A bolus injection of MgSO(4) was given intravenously over 1 to 2 minutes followed by continuous infusion for the next 2 to 7 days. RESULTS: Of the six patients, five responded completely to the initial bolus of 6.1 +/- 4.2 mg/kg (range, 2.3-12 mg/kg). One (a neonate with congenital LQTS) required a total of 30 mg/kg until complete TdP elimination. Continuous infusion was given at rates of 0.3 to 1.0 mg/kg/hr with no recurrence of TdP. SMg concentration was 3.9 +/- 1.0 mg/dL (2.9-5.4 mg/dL) immediately after bolus injection. CONCLUSION: Intravenous MgSO(4) infusion effectively treated TdP in children with LQTS. Optimal bolus dosage, infusion rates and SMg concentration were 3 to 12 mg/kg, 0.5 to 1.0 mg/kg/hr and 3 to 5 mg/dL, respectively.
No takes yet. Share an insight, caveat, or question.
Hoshino et al. (2004) conducted an observational in Torsades de Pointes in Children with Long QT Syndrome (n=6). Intravenous magnesium sulfate was evaluated on Complete response to initial bolus. Intravenous magnesium sulfate effectively treated torsades de pointes in children with long QT syndrome, with 5 of 6 patients responding completely to an initial bolus.
Synapse has enriched 10 related papers. Consider them for comparative context: